FoRx Therapeutics has initiated a first-in-human clinical trial of FORX-428, [...]

Boston-based Strand Therapeutics has raised $153 million in a Series [...]

A genetically targeted approach to depression treatment has shown promising [...]

Revolo Biotherapeutics says it is accelerating plans to bring a [...]

A newly published benchmark dataset is helping push variant detection [...]

New data presented at the Alzheimer’s Association International Conference 2025 [...]

A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]

No-code platform opens early access to generative binder design with [...]

OMNY Health has reached a major milestone, announcing that its [...]

In a significant shift for Alzheimer’s care, the Alzheimer’s Association [...]